WallStreetZenWallStreetZen

NASDAQ: XENE
Xenon Pharmaceuticals Inc Stock Ownership - Who owns Xenon Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Xenon Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher John KenneyChief Medical Officer2026-03-131,410$55.23
$77.87kSell
Andrea DifabioChief Legal Officer2026-03-131,342$55.23
$74.11kSell
Ian MortimerPRESIDENT CEO2026-03-137,308$55.23
$403.58kSell
Andrea DifabioChief Legal Officer2026-03-102,607$60.11
$156.70kSell
Christopher John KenneyChief Medical Officer2026-03-102,771$60.11
$166.56kSell
Ian MortimerPRESIDENT CEO2026-03-1011,269$60.11
$677.36kSell
Ian MortimerPRESIDENT CEO2026-03-0961,652$60.08
$3.70MSell
Ian MortimerPRESIDENT CEO2026-03-0965,000$62.06
$4.03MSell
Ian MortimerPRESIDENT CEO2026-03-0925,000$3.10
$77.50kBuy
Ian MortimerPRESIDENT CEO2026-03-0912,479$59.50
$742.50kSell

1 of 3

XENE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XENE insiders and whales buy or sell their stock.

XENE Shareholders

What type of owners hold Xenon Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC10.72%8,920,250$485.44MInstitution
Avoro Capital Advisors LLC6.52%5,424,444$295.20MInstitution
Blackrock Inc6.13%5,100,284$277.56MInstitution
Wellington Management Group LLP5.73%4,764,779$259.30MInstitution
Driehaus Capital Management LLC5.46%4,538,691$247.00MInstitution
Janus Henderson Group PLC4.91%4,084,034$222.25MInstitution
Capital International Investors4.10%3,414,959$185.84MInstitution
Polar Capital Holdings PLC2.96%2,465,694$134.18MInstitution
Braidwell LP2.19%1,825,076$99.32MInstitution
Commodore Capital LP2.16%1,800,000$97.96MInstitution

1 of 3

XENE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XENE97.13%2.87%Net SellingNet Selling
CRSP68.96%31.04%Net BuyingNet Selling
TERN85.84%14.16%Net SellingNet Selling
FOLD66.65%33.35%Net SellingNet Selling
ERAS70.55%27.68%Net BuyingNet Buying
View Top Biotech Stocks

Xenon Pharmaceuticals Stock Ownership FAQ

Who owns Xenon Pharmaceuticals?

Xenon Pharmaceuticals (NASDAQ: XENE) is owned by 101.52% institutional shareholders, 3.00% Xenon Pharmaceuticals insiders, and 0.00% retail investors. Evan A. Stein is the largest individual Xenon Pharmaceuticals shareholder, owning 1.04M shares representing 1.26% of the company. Evan A. Stein's Xenon Pharmaceuticals shares are currently valued at $55.73M.

If you're new to stock investing, here's how to buy Xenon Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.